(2018). Correction to: Cassidy et al., Disposition and metabolism of [14C]-galunisertib, a TGF-bRI kinase/ALK5 inhibitor, following oral administration in healthy subjects and mechanistic prediction of the effect of itraconazole on galunisertib pharmacokinetics. Xenobiotica, 48(4), x-xi. https://doi.org/10.1080/00498254.2018.1436416
Chicago Style (17th ed.) Citation"Correction to: Cassidy Et Al., Disposition and Metabolism of [14C]-galunisertib, a TGF-bRI Kinase/ALK5 Inhibitor, Following Oral Administration in Healthy Subjects and Mechanistic Prediction of the Effect of Itraconazole on Galunisertib Pharmacokinetics." Xenobiotica 48, no. 4 (2018): x-xi. https://doi.org/10.1080/00498254.2018.1436416.
MLA (9th ed.) Citation"Correction to: Cassidy Et Al., Disposition and Metabolism of [14C]-galunisertib, a TGF-bRI Kinase/ALK5 Inhibitor, Following Oral Administration in Healthy Subjects and Mechanistic Prediction of the Effect of Itraconazole on Galunisertib Pharmacokinetics." Xenobiotica, vol. 48, no. 4, 2018, pp. x-xi, https://doi.org/10.1080/00498254.2018.1436416.